The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Sleep apnea can cause a host of health problems ... People who took the placebo lost an average of 4 pounds and 6 pounds, ...

Sleep apnea “occurs when a person’s upper ... The approval of Zepbound follows a series of other weight loss drugs approved to treat medical conditions other than obesity and diabetes.

tells PEOPLE that some conditions improved by anti-obesity drugs are related to weight loss, not the drugs themselves.

Obesity is more than a cosmetic concern. It’s a chronic disease that can be treated with drugs like semaglutide (Wegovy) and ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The ...

The FDA approval comes amid growing discussion about the potential uses of weight loss drugs beyond treating obesity and diabetes. In addition to sleep apnea, there has been increasing interest in ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea ... which doesn't cover drugs solely for weight loss.Without insurance coverage ...